BioStem Technologies Releases Third Quarter 2018 Shareholder Update
December 10, 2018 11:48 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Dec. 10, 2018 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) (“BioStem Technologies” or the “Company”), a global life sciences corporation providing innovative...
TikaMobile Announces Business Intelligence CRM Solution for Market Access Teams to Increase Coverage and Pull-through Performance of Sales Teams
December 06, 2018 08:30 ET
|
TikaMobile, Inc.
NEW YORK, Dec. 06, 2018 (GLOBE NEWSWIRE) -- TikaMobile, the premier leader in cloud-based business intelligence and CRM software for the global life sciences industry, announces the latest...
Veloxis Increases Share Capital in Connection with Exercise of Warrants
December 05, 2018 23:19 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 20/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 06 December 2018 Veloxis Increases Share Capital in Connection with...
University of Notre Dame and Indiana Biosciences Research Institute partner to address health concerns
December 05, 2018 13:04 ET
|
Indiana Biosciences Research Institute
NOTRE DAME, Ind., Dec. 05, 2018 (GLOBE NEWSWIRE) -- The University of Notre Dame and the Indiana Biosciences Research Institute (IBRI) have signed a strategic alliance agreement to encourage...
Veloxis Pharmaceuticals Announces Financial Results for the First Nine Months of 2018
November 14, 2018 13:54 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 19/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 14 November 2018 Veloxis Pharmaceuticals Announces Financial Results for the First Nine Months of 2018 ...
Ira Duarte Promoted to Chief Financial Officer of Veloxis Pharmaceuticals A/S
October 31, 2018 14:21 ET
|
Veloxis Pharmaceuticals A/S
Company Release no. 18/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 31 October 2018 Ira Duarte Promoted to Chief Financial Officer...
Incysus Therapeutics to Participate in Panel at the 2018 Life Sciences Summit
October 22, 2018 08:00 ET
|
Incysus Therapeutics, Inc.
Panel Title: “Therapeutic Insight: Immuno-Oncology’s Next Generation Therapies” NEW YORK, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Incysus Therapeutics, Inc. (“Incysus”), a biopharmaceutical company...
Surgical Simulation Market to Reach $608.3 Million by 2023: P&S Intelligence
October 22, 2018 03:30 ET
|
Prescient & Strategic Intelligence
Surgical Simulation Market by Offering (Products [Laparoscopic, Endoscopic, Neurological, Gynecological, Cardiac, Arthroscopic], Services [Educational, Technical]), by End User (Academic &...
Veloxis to Present at Jefferies 2018 London Healthcare Conference
October 10, 2018 17:13 ET
|
Veloxis Pharmaceuticals A/S
Investor News no. 03/2018 To: NASDAQ Copenhagen A/S Copenhagen, Denmark, 10 October 2018 Veloxis to Present at the Jefferies 2018 London Healthcare...
IonSense and Cayman Chemical Collaboration Reaches 1000 Compound Milestone in Development of MS Library of Drugs of Abuse
October 04, 2018 10:06 ET
|
IonSense
SAUGUS, Mass., Oct. 04, 2018 (GLOBE NEWSWIRE) -- IonSense, Inc. has announced that in collaboration with Cayman Chemical, Inc. they have built and validated a mass spectral database of 1000...